Cigna Files 8-K on Financial Condition & Operations

TL;DR

**Cigna just dropped an 8-K on its financials, time to check the numbers!**

AI Summary

The Cigna Group filed an 8-K on February 2, 2024, to report on its results of operations and financial condition. This filing, under SEC File Number 001-38769, indicates that Cigna is providing an update on its financial performance, which is crucial for investors to understand the company's current health and future prospects. For shareholders, this matters because it offers transparency into the company's earnings and financial stability, directly influencing stock valuation and investment decisions.

Why It Matters

This filing provides investors with the latest financial results, which are essential for evaluating Cigna's performance and making informed investment decisions.

Risk Assessment

Risk Level: low — This 8-K is a routine disclosure of financial information, not indicating any immediate new risks but rather providing transparency.

Analyst Insight

A smart investor would review the detailed financial statements and results of operations once they become available to assess Cigna's performance and adjust their investment thesis accordingly.

Key Players & Entities

• Cigna Group (company) — the registrant filing the 8-K
• February 2, 2024 (date) — date of earliest event reported and filing date
• 001-38769 (dollar_amount) — Commission File Number
• 82-4991898 (dollar_amount) — IRS Employer Identification No.
• 900 Cottage Grove Road Bloomfield, Connecticut 06002 (company) — address of principal executive offices
• 860-226-6000 (dollar_amount) — registrant's telephone number
• CI (company) — trading symbol for Common Stock
• New York Stock Exchange, Inc. (company) — exchange where Common Stock is registered

FAQ

From the Filing

0000950159-24-000033.txt : 20240202 0000950159-24-000033.hdr.sgml : 20240202 20240202061528 ACCESSION NUMBER: 0000950159-24-000033 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 16 CONFORMED PERIOD OF REPORT: 20240202 ITEM INFORMATION: Results of Operations and Financial Condition ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20240202 DATE AS OF CHANGE: 20240202 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Cigna Group CENTRAL INDEX KEY: 0001739940 STANDARD INDUSTRIAL CLASSIFICATION: HOSPITAL & MEDICAL SERVICE PLANS [6324] ORGANIZATION NAME: 02 Finance IRS NUMBER: 824991898 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-38769 FILM NUMBER: 24588729 BUSINESS ADDRESS: STREET 1: 900 COTTAGE GROVE ROAD CITY: BLOOMFIELD STATE: CT ZIP: 06002 BUSINESS PHONE: 8602266000 MAIL ADDRESS: STREET 1: 900 COTTAGE GROVE ROAD CITY: BLOOMFIELD STATE: CT ZIP: 06002 FORMER COMPANY: FORMER CONFORMED NAME: Cigna Corp DATE OF NAME CHANGE: 20181221 FORMER COMPANY: FORMER CONFORMED NAME: Halfmoon Parent, Inc. DATE OF NAME CHANGE: 20180508 8-K 1 cigna8k.htm THE CIGNA GROUP FORM 8-K false 0001739940 0001739940 2024-02-02 2024-02-02 iso4217:USD xbrli:shares iso4217:USD xbrli:shares       UNITED STATES   SECURITIES AND EXCHANGE COMMISSION   Washington, D.C. 20549   FORM 8-K     CURRENT REPORT   Pursuant to Section 13 or 15(d) of the   Securities Exchange Act of 1934   Date of Report (Date of earliest event reported) February 2, 2024   The Cigna Group   (Exact name of registrant as specified in its charter)     Delaware (State or other jurisdiction of   incorporation) 001-38769 (Commission File Number) 82-4991898 (IRS Employer Identification No.)   900 Cottage Grove Road Bloomfield , Connecticut 06002   (Address of principal executive offices) (Zip Code)   Registrant’s telephone number, including area code:   ( 860 ) 226-6000   Not Applicable   (Former name or former address, if changed since last report)   Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:   ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)   ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)   ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))   ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))   Securities registered pursuant to Section 12(b) of the Act:   Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, Par Value $0.01 CI New York Stock Exchange , Inc.   Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).   Emerging growth company ☐   If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐             Item 2.02 Results of Operations and Financial Condition.   On February 2, 2024, The Cigna Group issued a press release announcing results for the three months and year ended December 31, 2023. The press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and incorporated herein by reference.   This information shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as ame